Which peptides are studied for cancer?

Short answer

11 profiles here are grouped under “Cancer”: 10 FDA-approved and 1 not FDA-approved.

Each entry below quotes its profile and links to the full answer there.

FDA-approved 10

Not FDA-approved 1

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    Drugs@FDA: KYPROLIS (carfilzomib), NDA 202714 · original approval July 20, 2012 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  2. 2
    KYPROLIS (carfilzomib) for injection · SPL version 59 · published 2025-06-26 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  3. 3
    FIRMAGON (degarelix) kit · SPL version 18 · published 2024-02-01 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  4. 4
    Drugs@FDA: FIRMAGON (degarelix acetate), NDA 022201 · original approval December 24, 2008 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  5. 5
    Drugs@FDA: NETSPOT (gallium dotatate Ga-68), NDA 208547 · original approval June 1, 2016 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  6. 6
    NETSPOT (kit for the preparation of gallium Ga 68 dotatate injection) · SPL version 23 · published 2026-07-07 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026

  7. 7
    ZOLADEX (goserelin) implant · SPL version 9 · published 2026-03-26 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  8. 8
    Drugs@FDA: ZOLADEX (goserelin acetate), NDA 019726 · original approval December 29, 1989 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  9. 9
    Lanreotide acetate injection · SPL version 3 · published 2025-06-02 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  10. 10
    Drugs@FDA application NDA022074 · original submission status AP · 2007-08-30 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  11. 11
    Drugs@FDA application NDA215395 · original submission status AP · 2021-12-17 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  12. 12
    Drugs@FDA application ANDA217193 · original submission status AP · 2024-05-21 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  13. 13
    ELIGARD (leuprolide acetate) injection, suspension, extended release · SPL version 19 · published 2026-05-11 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  14. 14
    Drugs@FDA application NDA019010 · original submission status AP · 1985-04-09 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  15. 15
    Drugs@FDA application NDA019732 · original submission status AP · 1989-01-26 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  16. 16
    Drugs@FDA application NDA021343 · original submission status AP · 2002-01-23 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  17. 17
    Vobrig (leuprolide acetate): NDA 213225 approval letter, August 26, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  18. 18
    Drugs@FDA application NDA213225 · original submission status AP · 2026-08-26 · dataset 2026-11-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked November 15, 2026

  19. 19
    LUTATHERA (lutetium Lu 177 dotatate) injection · SPL version 12 · published 2026-01-16 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  20. 20
    Drugs@FDA: LUTATHERA (lutetium Lu-177 dotatate), NDA 208700 · original approval January 26, 2018 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  21. 21
    Drugs@FDA: BEXLUTRY (lutetium Lu-177 dotatate), NDA 218525 · original approval September 14, 2026 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  22. 22
    APHEXDA (motixafortide) for injection · SPL version 3 · published 2026-10-19 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  23. 23
    Drugs@FDA: APHEXDA (motixafortide acetate), NDA 217159 · original approval September 8, 2023 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  24. 24
    Octreotide acetate injection, solution · SPL version 2 · published 2026-02-02 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  25. 25
    Drugs@FDA application NDA019667 · original submission status AP · 1988-10-21 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  26. 26
    Drugs@FDA application NDA021008 · original submission status AP · 1998-11-25 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  27. 27
    Drugs@FDA application NDA208232 · original submission status AP · 2020-06-26 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  28. 28
    Drugs@FDA application NDA213224 · original submission status AP · 2024-09-27 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  29. 29
    TRELSTAR (triptorelin pamoate) kit · SPL version 20 · published 2026-07-10 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  30. 30
    Drugs@FDA: TRELSTAR (triptorelin pamoate), NDA 020715 · original approval June 15, 2000 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  31. 31
    FDA evaluation of thymosin alpha-1-related bulk drug substances, November 15, 2024 (briefing document for the December 4, 2024 Pharmacy Compounding Advisory Committee) ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  32. 32
    December 4, 2024 Meeting of the Pharmacy Compounding Advisory Committee · minutes ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  33. 33
    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026